Sentences with phrase «permanent hair loss»

Adding permanent hair loss to an already difficult and painful situation can be devastating.

Living with permanent hair loss after battling cancer can be a constant reminder of something you just want to forget.

Many women are considering filing a Taxotere lawsuit, because they were never made aware of the fact they faced the possibility of permanent hair loss.

The manufacturer, Sanofi - Aventis, had different results, claiming that only 3 percent of patients experience permanent hair loss.

I can't promise this to everyone because I have had a couple moms (over the 1000 moms we have served) that didn't regain hair and actually had some more permanent hair loss.

However, when we're exposed to significant or lasting stress (divorce, death, serious financial worries) or big hormonal changes (such as during menopause or the post-pregnancy period), this may spark a change in our body's routine physiological functions and cause temporary or even permanent hair loss.

Gomez Trial Attorneys makes no representation that the subject of this photo suffers permanent hair loss as a result of Taxotere.

We also handle some Class Action lawsuits, including the Takata Airbag recall, Mirena IUD defects, and permanent hair loss due to Taxotere.

With 9.2 percent of women experiencing permanent hair loss, and up to 15 percent experiencing long - term significant hair loss, there is obvious cause for concern.

Some medications can lead to temporary or permanent hair loss.

According to Dr. Lenzy, the No. 1 cause of hair loss in African - American women is a condition called central centrifugal cicatricial alopecia (CCCA), a disorder in which inflammation and destruction of hair follicles causes scarring and permanent hair loss.

Permanent hair loss can be devastating for a woman.

Taxotere is currently under investigation for its failure to warn physicians and patients about the link to permanent hair loss.

In one recent study, researchers found that permanent hair loss has occurred in 9.2 percent of women using Taxotere.

Women being treated for breast cancer account for the majority of the permanent hair loss cases linked to Taxotere.

There are currently at least 33 pending federal complaints that accuse Sanofi - Aventis of continuing to market Taxotere as a superior alternative to other chemotherapy medications, despite knowing that the drug was linked to permanent hair loss.